AzTrials
AzTrials

SuicidalityNCT07256496

Enhanced Dialectical Behavior Therapy for Adolescents

A study testing Enhanced DBT-A in people with Suicidality, run by Compass Behavioral Health at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Suicide is a leading cause of death and significant concerns for adolescents and young adults. Dialectical Behavior Therapy for Adolescents (DBT-A) is an evidence-based intervention that effectively reduces life-threatening behaviors. Read more about this study

Who is it for?
Ages 13 to 25 years
Conditions the study is for
Suicidality
What is being tested?
Enhanced DBT-A
Could I receive a placebo?
No, everyone receives an active treatment
How many people
47 participants
Where
1 siteUnited States
Study dates
17 Oct 2014to 26 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 25 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • appropriateness for Stage 1 DBT, completion of all assessments within the designated timeframe, a non-zero score on the Columbia-Suicide Severity Rating Scale (C-SSRS) at intake, and participation in at least one ISCS between intake and 1 year from the first individual therapy session.

Who cannot join

  • presenting with active psychosis, a primary diagnosis of substance use, who did not consent to data collection, or who had a zero score on the C-SSRS at intake

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Compass Behavioral Health

    Tustin, California, 92780

Other trials in United States

About this study

Official title: Enhanced Dialectical Behavior Therapy for Adolescents: Impacts of Individualized Skills Coaching on Constructs of Suicidality

Suicide is a leading cause of death and significant concerns for adolescents and young adults. Dialectical Behavior Therapy for Adolescents (DBT-A) is an evidence-based intervention that effectively reduces life-threatening behaviors. Limited research examines the impact of adding individualized skills coaching sessions (ISCS) to the DBT-A model, a novel intervention referred to in this paper as "Enhanced DBT-A". This study evaluates the effectiveness of Enhanced DBT-A in reducing suicidality over 1 year of treatment in an outpatient and intensive outpatient setting.

Conditions
Suicidality
Being tested
Enhanced DBT-A
Medical subject headings
Suicidal Ideation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Enhanced DBT-ABehavioural

    Participants engaged in Enhanced DBT-A services, including individual therapy, group skills training, phone coaching, and ISCS. Participants completed assessment batteries at intake, 6 months, and 1 year, and the outcome measures assessed participants' severity and intensity of suicidal ideation (SI), reasons for living, and depressive symptoms.

Study groups in NCT07256496
Study groupRoleWhat they receive
Enhanced DBT-A GroupExperimentalParticipants engaged in Enhanced DBT-A services, including individual therapy, group skills training, phone coaching, and ISCS. Participants completed assessment batteries at intake, 6 months, and 1 year, and the outcome measures assessed participants' severity and intensity of suicidal ideation (SI), reasons for living, and depressive symptoms.
Receives: Behavioral: Enhanced DBT-A

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reasons for Living Inventory for Adolescents (RFL-A)

    The Reasons for Living Inventory for Adolescents (RFL-A; Osman et al, 1998) is a 32-item self-report questionnaire that assesses adaptive reasons that may prevent an adolescent from engaging in life-threatening behavior.

    Measured: 1 year

  2. PHQ-9

    The current study administered the PHQ-9 to participants 18 years and older. The PHQ-9 (Kroenke et al, 2001) is a widely-used and psychometrically-robust self-report measure used to assess the prevalence of depressive symptoms in adults during a two-week period.

    Measured: 1 year

  3. Columbia-Suicide Severity Rating Scale - Self Report Screener - Recent (C-SSRS).

    To capture the severity and intensity of participants' SI and their corresponding suicide risk, we used items from the Columbia-Suicide Severity Rating Scale - Screen Version - Recent (C-SSRS; Posner et al, 2011).

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Dec 2025
  2. Study start17 Oct 2014
  3. Primary completion26 Aug 2022
  4. Study completion26 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
47 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07256496
Sponsor's protocol ID
Pro00078098
Status last verified
Nov 2025
First submitted
20 Nov 2025
Last updated
1 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Plakos Szabo M, Neves SL, Huerta PL, Smoski MJ. Enhanced Dialectical Behavior Therapy for Adolescents: Impacts of Individualized Skills Coaching on Constructs of Suicidality. Evid Based Pract Child Adolesc Ment Health. 2026;11(3):474-490. doi: 10.1080/23794925.2026.2617586. Epub 2026 Jan 19.

    PubMed 42847855

Questions about this trial

What is this clinical trial studying?

A study testing Enhanced DBT-A in people with Suicidality, run by Compass Behavioral Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reasons for Living Inventory for Adolescents (RFL-A) (time frame: 1 year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07256496, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in